` ULTI (Ultimovacs ASA) vs Oslo OBX Comparison - Alpha Spread

U
ULTI
vs
O
Oslo OBX

Over the past 12 months, ULTI has underperformed Oslo OBX, delivering a return of -29% compared to the Oslo OBX's +17% growth.

Stocks Performance
ULTI vs Oslo OBX

Loading
ULTI
Oslo OBX
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ULTI vs Oslo OBX

Loading
ULTI
Oslo OBX
Difference
www.alphaspread.com

Performance By Year
ULTI vs Oslo OBX

Loading
ULTI
Oslo OBX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Ultimovacs ASA vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Ultimovacs ASA
Glance View

Market Cap
293.3m NOK
Industry
Biotechnology

Ultimovacs AS operates as a pharmaceutical company. The company is headquartered in Oslo, Oslo. The company went IPO on 2019-06-03. The firm's lead product candidate is UV1, a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen telomerase. UV1 is being developed as a therapeutic cancer vaccine which may serve as a platform for use in combination with other immuno-oncology drugs which require an ongoing T cell response for their mode of action. The firm is performing a broad clinical development program with clinical trials in Europe and the USA.

ULTI Intrinsic Value
9.71 NOK
Overvaluation 33%
Intrinsic Value
Price
U
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett